NNVC logo

NNVCNanoViricides Inc

$1.34
$0.00
(0.00%)
Pre-Market
Updated: 05:04 AM EDT·Prev Close $1.34
Mkt Cap$32.18M
Vol1,510.00
News
all
press releases
News Placeholder
NNVC Stock Up 17% Today: What’s Driving The Rally?
U.S. FDA granted Orphan Drug Designation to NanoViricides’ broad-spectrum antiviral candidate NV-387 for the treatment of measles.
Stocktwits
<
...
1
>